These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 22519360)

  • 1. Association of XPC polymorphisms with susceptibility and clinical outcome to chemotherapy in breast cancer patients.
    Yang X; Liu D; Wu H; Kang H; Pang H; Huang D; Sha X; Wang E; Wang Z; Wei M
    Cancer Sci; 2012 Jul; 103(7):1207-14. PubMed ID: 22519360
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association of DNA repair gene XPC Ala499Val (rs2228000 C>T) and Lys939Gln (rs2228001 A>C) polymorphisms with the risk of chronic myeloid leukemia: A case-control study in a South Indian population.
    Lakkireddy S; Aula S; Kapley A; Gundeti S; Kutala VK; Jamil K
    J Gene Med; 2021 Jul; 23(7):e3339. PubMed ID: 33829606
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Correlation of XPC Ala499Val and Lys939Gln polymorphisms to risks of esophageal squamous cell carcinoma and gastric cardiac adenocarcinoma].
    Zhou RM; Li Y; Wang N; Zhang XJ; Dong XJ; Guo W
    Ai Zheng; 2006 Sep; 25(9):1113-9. PubMed ID: 16965652
    [TBL] [Abstract][Full Text] [Related]  

  • 4. XPC Lys939Gln and Ala499Val polymorphisms in colorectal cancer susceptibility: a meta-analysis of case-control studies.
    Liu C; Yin Q; Ying M; Lin J; Li L; Jiao G; Wang M; Wang Y
    Mol Biol Rep; 2014 Feb; 41(2):1171-8. PubMed ID: 24385304
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association of XPC Polymorphisms with Cutaneous Malignant Melanoma Risk: Evidence from a Meta-Analysis.
    Asadian F; Niktabar SM; Ghelmani Y; Kargar S; Akbarian E; Emarati SA; Sadeghizadeh-Yazdi J; Neamatzadeh H
    Acta Medica (Hradec Kralove); 2020; 63(3):101-112. PubMed ID: 33002396
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Association of XPC gene polymorphisms with breast cancer risk].
    Wu YY; Ma XY; Yao KY; Li QL; Chen K
    Zhejiang Da Xue Xue Bao Yi Xue Ban; 2011 May; 40(3):252-8. PubMed ID: 21671483
    [TBL] [Abstract][Full Text] [Related]  

  • 7. DNA repair genes XPC, XPG polymorphisms: relation to the risk of colorectal carcinoma and therapeutic outcome with Oxaliplatin-based adjuvant chemotherapy.
    Liu D; Wu HZ; Zhang YN; Kang H; Sun MJ; Wang EH; Yang XL; Lian MQ; Yu ZJ; Zhao L; Olopade OI; Wei MJ
    Mol Carcinog; 2012 Oct; 51 Suppl 1():E83-93. PubMed ID: 22213216
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Associations between polymorphisms of the XPC gene and lung cancer susceptibility: a meta-analysis.
    Zhu ML; Hua RX; Zheng L
    Tumour Biol; 2014 Apr; 35(4):2931-9. PubMed ID: 24375193
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Ala499Val (C > T) and Lys939Gln (A > C) polymorphisms of the XPC gene: their correlation with male infertility].
    Liang J; Lu CC; Gu AH; Xia YK; Lü ZM; Xu J; Shi GY; Wang MS; Wang XR
    Zhonghua Nan Ke Xue; 2010 Mar; 16(3):244-9. PubMed ID: 20369554
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Polymorphisms in the XPC gene affect urinary bladder cancer risk: a case-control study, meta-analyses and trial sequential analyses.
    Sankhwar M; Sankhwar SN; Bansal SK; Gupta G; Rajender S
    Sci Rep; 2016 Jun; 6():27018. PubMed ID: 27246180
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Association of XPC and XPG polymorphisms with the risk of hepatocellular carcinoma].
    Li LM; Zeng XY; Ji L; Fan XJ; Li YQ; Hu XH; Qiu XQ; Yu HP
    Zhonghua Gan Zang Bing Za Zhi; 2010 Apr; 18(4):271-5. PubMed ID: 20460046
    [TBL] [Abstract][Full Text] [Related]  

  • 12. XPC gene variants: a risk factor for recurrence of urothelial bladder carcinoma in patients on BCG immunotherapy.
    Gangwar R; Mandhani A; Mittal RD
    J Cancer Res Clin Oncol; 2010 May; 136(5):779-86. PubMed ID: 19924443
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Associations of Lys939Gln and Ala499Val polymorphisms of the XPC gene with cancer susceptibility: a meta-analysis.
    He J; Shi TY; Zhu ML; Wang MY; Li QX; Wei QY
    Int J Cancer; 2013 Oct; 133(8):1765-75. PubMed ID: 23400628
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The association of XPC polymorphisms and tea drinking with colorectal cancer risk in a Chinese population.
    Wu Y; Jin M; Liu B; Liang X; Yu Y; Li Q; Ma X; Yao K; Chen K
    Mol Carcinog; 2011 Mar; 50(3):189-98. PubMed ID: 21104992
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Polymorphisms in XPC gene and risk for prostate cancer.
    Said R; Bougatef K; Setti Boubaker N; Jenni R; Derouiche A; Chebil M; Ouerhani S
    Mol Biol Rep; 2019 Feb; 46(1):1117-1125. PubMed ID: 30552616
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A33512C and Intronic Poly(AT) Insertion/Deletion (PAT-/+) Polymorphisms of the XPC Gene and Their Association With the Risk of Breast Cancer.
    Qazvini MG; Salehi Z; Mashayekhi F; Saedi HS
    Clin Breast Cancer; 2020 Dec; 20(6):e771-e777. PubMed ID: 32682659
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Associations of ABCB1 and XPC genetic polymorphisms with susceptibility to colorectal cancer and therapeutic prognosis in a Chinese population.
    Yue AM; Xie ZB; Zhao HF; Guo SP; Shen YH; Wang HP
    Asian Pac J Cancer Prev; 2013; 14(5):3085-91. PubMed ID: 23803084
    [TBL] [Abstract][Full Text] [Related]  

  • 18. XPC as breast cancer susceptibility gene: evidence from genetic profiling, statistical inferences and protein structural analysis.
    Malik SS; Zia A; Rashid S; Mubarik S; Masood N; Hussain M; Yasmin A; Bano R
    Breast Cancer; 2020 Nov; 27(6):1168-1176. PubMed ID: 32562189
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Polymorphisms in XPC and XPD genes modulate DNA damage in pesticide-exposed agricultural workers of Punjab, North-West India.
    Kaur K; Kaur R
    Mol Biol Rep; 2020 Jul; 47(7):5253-5262. PubMed ID: 32562175
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Acute myeloid leukemia outcome: role of nucleotide excision repair polymorphisms in intermediate risk patients.
    Strom SS; Estey E; Outschoorn UM; Garcia-Manero G
    Leuk Lymphoma; 2010 Apr; 51(4):598-605. PubMed ID: 20141440
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.